One pre-clinical study evaluating a MUC-1 CAR-T cellular therapy in a CCA cell line demonstrated significant upregulation in cytokine production of IFN-γ and granzyme B when compared to un-transduced T-cells [59]. The gene discussed is MUC1; the disease is cholangiocarcinoma.